<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03703713</url>
  </required_header>
  <id_info>
    <org_study_id>COOH</org_study_id>
    <nct_id>NCT03703713</nct_id>
  </id_info>
  <brief_title>Colloid Osmotic Pressure and Osmolality in Hyponatremia</brief_title>
  <official_title>Colloid Osmotic Pressure and Osmolality in Hyponatremia. Additional Diagnostic Aspects and Guide to Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyponatremia (serum sodium of less than 135 mmol/L)is a very common electrolyte disorder. The
      reasons for the disorder varies as well as if it is acute or chronic.

      In this study we wish to follow changes in colloid osmotic pressure and osmolality during the
      initial treatment hours. We also wish to use mass balance for the calculation of body
      compartments and to detect fluid translocation between these.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with hyponatremia arriving att the intensive care unit are asked to participate in
      the study. The first blood samples are collected before initializing the treatment as well as
      measurements of body compartments with a bioimpedance analyzer. Collected blood samples are
      electrolytes (Sodium, Potassium and Chloride), colloid osmotic pressure, osmolality and
      hemoglobin. These samples are repeated at 4 and 8 hours after start of the study. Amount of
      infused fluid as well as electrolytes are recorded. Urine volume is measured and urine
      samples are analyzed for the loss of electrolytes.

      Additional samples for guidance of treatment are collected every hour.

      Hopefully the addition of colloid osmotic pressure, osmolality and mass balance can be
      beneficial in the diagnosis of the reason for the disorder as well as for the treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Colloid osmotic pressure</measure>
    <time_frame>8 hours</time_frame>
    <description>Measurement of colloid osmotic pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body compartments</measure>
    <time_frame>8 hours.</time_frame>
    <description>Bioimpedance analysis is performed every 4 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body compartments</measure>
    <time_frame>8 hours</time_frame>
    <description>Mass balance Sodium and Chloride</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hyponatremia</condition>
  <arm_group>
    <arm_group_label>Hyponatremia</arm_group_label>
    <description>Patients treated for hyponatremia (&lt;125 mmol/L Sodium) in the intensive care department.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium chloride</intervention_name>
    <description>Treatment with Sodium chloride</description>
    <arm_group_label>Hyponatremia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated for severe hyponatremia, at the intensive care unit.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients treated for Hyponatremia at the intensive care unit.

        Exclusion Criteria:

          -  Circulatory instable patients in need of treatment for more than the hyponatremia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joachim Zdolsek, MD, PhD</last_name>
    <phone>+46101031821</phone>
    <email>joachim.zdolsek@regionostergotland.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Svensson, MD, Head of department</last_name>
    <phone>+46101040000</phone>
    <email>robert.svensson@regionostergotland.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Intensive Care Unit, Vrinnevi Hospital</name>
      <address>
        <city>Norrk√∂ping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Zdolsek, MD, PhD</last_name>
      <phone>+46 101031821</phone>
      <email>joachim.zdolsek@regionostergotland.se</email>
    </contact>
    <contact_backup>
      <last_name>Robert Svensson, MD, Head of department</last_name>
      <phone>+46 101040000</phone>
      <email>robert.svensson@regionostergotland.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 9, 2018</study_first_submitted>
  <study_first_submitted_qc>October 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2018</study_first_posted>
  <last_update_submitted>October 11, 2018</last_update_submitted>
  <last_update_submitted_qc>October 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Joachim Zdolsek</investigator_full_name>
    <investigator_title>MD, PhD, Assoc prof, consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

